Seres Therapeutics, Inc. (MCRB) stock
MCRBNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.41+0.00 (0.00%)
Close on Nov 17, 2026Market cap $14.02MP/E –Yield –
Seres Therapeutics enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Seres Therapeutics's enterprise value was -$852.65K on Nov 11, 2026, against $101.37M a year earlier. Over the last 5 years it ranged from -$5.96M to $664.49M, with a median of $103.12M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | -$852.65K | -101.2% |
| 2025 | Dec 31, 2025 | $74.11M | +14.5% |
| 2024 | Dec 31, 2024 | $64.74M | -37.2% |
| 2023 | Dec 29, 2023 | $103.12M | -79.6% |
| 2022 | Dec 30, 2022 | $506.37M | +16.7% |
| 2021 | Dec 31, 2021 | $433.77M | -77.6% |
| 2020 | Dec 31, 2020 | $1.94B | +1129.9% |
| 2019 | Dec 31, 2019 | $157.69M | +41.2% |
| 2018 | Dec 31, 2018 | $111.72M | -53.4% |
| 2017 | Dec 29, 2017 | $239.50M | +22.1% |
| 2016 | Dec 30, 2016 | $196.14M | -83.0% |
| 2015 | Dec 31, 2015 | $1.15B | – |
See a number that looks wrong?